316 related articles for article (PubMed ID: 30601866)
1. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of canine prostate-specific membrane antigen.
Schmidt S; Fracasso G; Colombatti M; Naim HY
Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells.
Wu LY; Johnson JM; Simmons JK; Mendes DE; Geruntho JJ; Liu T; Dirksen WP; Rosol TJ; Davis WC; Berkman CE
Prostate; 2014 May; 74(5):451-7. PubMed ID: 24449207
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor vasculature with aptamer-functionalized doxorubicin-polylactide nanoconjugates for enhanced cancer therapy.
Tang L; Tong R; Coyle VJ; Yin Q; Pondenis H; Borst LB; Cheng J; Fan TM
ACS Nano; 2015 May; 9(5):5072-81. PubMed ID: 25938427
[TBL] [Abstract][Full Text] [Related]
5. Verification of a canine PSMA (FolH1) antibody.
Wagner S; Maibaum D; Pich A; Nolte I; Murua Escobar H
Anticancer Res; 2015 Jan; 35(1):145-8. PubMed ID: 25550545
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor concentrations in body cavity effusions in dogs.
Clifford CA; Hughes D; Beal MW; Henry CJ; Drobatz KJ; Sorenmo KU
J Vet Intern Med; 2002; 16(2):164-8. PubMed ID: 11899032
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
9. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
Chen W; Lee Z; Awadallah A; Zhou L; Xin W
Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
[TBL] [Abstract][Full Text] [Related]
10. N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.
Whitaker HC; Shiong LL; Kay JD; Grönberg H; Warren AY; Seipel A; Wiklund F; Thomas B; Wiklund P; Miller JL; Menon S; Ramos-Montoya A; Vowler SL; Massie C; Egevad L; Neal DE
Oncogene; 2014 Nov; 33(45):5274-87. PubMed ID: 24240687
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific membrane antigen as a marker of pancreatic cancer cells.
Ren H; Zhang H; Wang X; Liu J; Yuan Z; Hao J
Med Oncol; 2014 Mar; 31(3):857. PubMed ID: 24477651
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
Tolkach Y; Gevensleben H; Bundschuh R; Koyun A; Huber D; Kehrer C; Hecking T; Keyver-Paik MD; Kaiser C; Ahmadzadehfar H; Essler M; Kuhn W; Kristiansen G
Breast Cancer Res Treat; 2018 Jun; 169(3):447-455. PubMed ID: 29455299
[TBL] [Abstract][Full Text] [Related]
13. Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
Crowley MJ; Scognamiglio T; Liu YF; Kleiman DA; Beninato T; Aronova A; Liu H; Jhanwar YS; Molina A; Tagawa ST; Bander NH; Zarnegar R; Elemento O; Fahey TJ
J Clin Endocrinol Metab; 2016 Mar; 101(3):981-7. PubMed ID: 26771706
[TBL] [Abstract][Full Text] [Related]
14. PSMA expression is highly homogenous in primary prostate cancer.
Tsourlakis MC; Klein F; Kluth M; Quaas A; Graefen M; Haese A; Simon R; Sauter G; Schlomm T; Minner S
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):449-55. PubMed ID: 26153794
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human.
Aggarwal S; Ricklis RM; Williams SA; Denmeade SR
Prostate; 2006 Jun; 66(9):903-10. PubMed ID: 16496413
[TBL] [Abstract][Full Text] [Related]
16. Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance.
Wang HL; Wang SS; Song WH; Pan Y; Yu HP; Si TG; Liu Y; Cui XN; Guo Z
PLoS One; 2015; 10(5):e0125924. PubMed ID: 25978404
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.
Hofman MS; Hicks RJ; Maurer T; Eiber M
Radiographics; 2018; 38(1):200-217. PubMed ID: 29320333
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Smiraglia DJ; Bshara W; Andrews C; Schwaller J; South S; Higgs D; Lele S; Herrmann F; Odunsi K
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):571-7. PubMed ID: 18349274
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
Hofman MS; Murphy DG; Williams SG; Nzenza T; Herschtal A; Lourenco RA; Bailey DL; Budd R; Hicks RJ; Francis RJ; Lawrentschuk N
BJU Int; 2018 Nov; 122(5):783-793. PubMed ID: 29726071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
